Epiqmax is a spin-off from LMU Munich. At EpiQMAx, we measure so-called epigenetic modifications. These modifications are located in the nucleus of our body's cells and can be altered by environmental influences. These modifications also influence a variety of diseases, allowing us to use our measurements to establish a direct connection between our current lifestyle and potential diseases.
This startup is no longer active in the Munich startup ecosystem.
Reasons for this may be:
- Dissolution or takeover of the company
- Relocation from Munich
- Change in the business model
Facts
Contact
2018
Founding year
Stage
Company location
Epiqmax GmbH
Großhaderner Straße 9
82152 Planegg
[AdditionalInfo]
[Fundings] [Analytics] [Insights]
You might also be interested in
Deals
Epiqmax acquired by Moleqlar
In the third quarter of this year, the biotech startup Epiqmax filed for insolvency with the local court. Now, the Berlin-based company Moleqlar has sued the Munich-based epigenetics specialist…
7 Questions
Biotech startup Epiqmax
The team behind the biotech startup Epiqmax met in the histone modification group at the Biomedical Center in Munich. With their knowledge and many years of experience, they…
News
Fresh capital for THEVA GmbH
BayBG is investing in the production of superconductors, or more precisely, in THEVA GmbH. It was able to…
